Acceso abierto

Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient

Lina Savsek

Lina Savsek

Department of Neurology, General Hospital CeljeCelje, Slovenia
Buscar este autor en
Sciendo|Google Scholar
Savsek, Lina
 y 
Tanja Ros Opaskar

Tanja Ros Opaskar

Unit of Neurology, Institute of Oncology LjubljanaLjubljana, Slovenia
Buscar este autor en
Sciendo|Google Scholar
Opaskar, Tanja Ros
  
16 feb 2016
Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Case Report
Publicado en línea: 16 feb 2016
Páginas: 87 - 93
Recibido: 27 may 2014
Aceptado: 21 ago 2014
DOI: https://doi.org/10.1515/raon-2014-0042
Palabras clave
© 2016 Radiol Oncol
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1.

(A) MRI at time of diagnosis demonstrating multiple T2 and (B) fluid attenuated inversion recovery (FLAIR) hyperintense parenchymal lesions, located in both cerebral and cerebellar hemispheres, with mild surrounding edema. (C) On T1 sequences, these lesions were hypointense. (D) After contrast administration, only moderate rim enhancement was seen.
(A) MRI at time of diagnosis demonstrating multiple T2 and (B) fluid attenuated inversion recovery (FLAIR) hyperintense parenchymal lesions, located in both cerebral and cerebellar hemispheres, with mild surrounding edema. (C) On T1 sequences, these lesions were hypointense. (D) After contrast administration, only moderate rim enhancement was seen.

Figure 2.

Full body 18F-FDG PET/CT revealing focal hypometabolism, corresponding to toxoplasma lesions. The largest lesion is seen in the right occipital lobe.
Full body 18F-FDG PET/CT revealing focal hypometabolism, corresponding to toxoplasma lesions. The largest lesion is seen in the right occipital lobe.

Figure 3.

Lesion size and edema reduction after 6 weeks of intensive antibiotic therapy, as demonstrated by (A) fluid attenuated inversion recovery (FLAIR) and (B) T1 sequence.
Lesion size and edema reduction after 6 weeks of intensive antibiotic therapy, as demonstrated by (A) fluid attenuated inversion recovery (FLAIR) and (B) T1 sequence.

Figure 4.

Follow-up MRI after 4 months reveals further reduction of lesion size. (A) T1 sequence + gadolinium, (B) T2 sequence.
Follow-up MRI after 4 months reveals further reduction of lesion size. (A) T1 sequence + gadolinium, (B) T2 sequence.
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicina, Medicina Clínica, Medicina Interna, Hematología, oncología, Radiología
RSS Feed de revista